Hemoglobinuria: Clinical Trials

4 trials for Hemoglobinuria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Hemoglobinuria: new trials by email Literature Review of Hemoglobinuria trials Research Report on Hemoglobinuria

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH
Pegcetacoplan - PNH
Phase 2CompletedApellis Pharmaceuticals, Inc.42018-08-162020-12-22
A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
ACH-0144471 - Paroxysmal Nocturnal Hemoglobinuria
Phase 2CompletedAlexion Pharmaceuticals, Inc.82017-06-222023-03-14
Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Danicopan - Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 2CompletedAlexion Pharmaceuticals, Inc.102017-03-312022-06-23
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
CliniMACS, Stem cell transplantation, Fludarabine - Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML)
Phase 2CompletedSt. Jude Children's Research Hospital732007-12-142020-04-14

Narrower conditions

Hemoglobinuria, Paroxysmal (4)  ·  Anemia (1)  ·  Hematologic Diseases (1)  ·  Hemolysis (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Anemia, Hemolytic (4)  ·  Bone Marrow Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Proteinuria (4)  ·  Signs and Symptoms (4)  ·  Urination Disorders (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Urological Manifestations (4)  ·  Anemia (3)  ·  Hematologic Diseases (3)

Interventions

danicopan (2)  ·  Alemtuzumab (1)  ·  Antilymphocyte Serum (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Melphalan (1)  ·  Muromonab-CD3 (1)  ·  Mycophenolic Acid (1)  ·  Rituximab (1)  ·  Stem Cell Transplantation (1)  ·  Thiotepa (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  pegcetacoplan (1)

Sponsors

Alexion Pharmaceuticals, Inc. (2)  ·  Apellis Pharmaceuticals, Inc. (1)  ·  St. Jude Children's Research Hospital (1)

Countries

Italy (2)  ·  New Zealand (2)  ·  South Korea (2)  ·  Bulgaria (1)  ·  Serbia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Brandon Triplett, MD (1)  ·  Federico Grossi, MD, PhD (1)

Results publications

PMID 33121236, PMID 35869170, PMID 41124654

NIH funding

2016 (1), 2017 (1)